John Pullman MD

Internal Medicine•Butte, MT

Critical Care Medicine, Hospital Medicine/Hospitalist, Infectious Disease

Infectious Disease Consultant

Join to View Full Profile

300 W Mercury StButte, MT 59701
Phone+1 406-723-1300
Fax+1 406-723-1360

Education & Training

University of Nebraska Medical Center College of MedicineResidency, Internal Medicine, 1977 - 1980
University of Rochester School of Medicine and DentistryClass of 1977

Certifications & Licensure

MT State Medical License 1982 - 2026
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Critical Care Medicine
American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification PrimeSUITE EHR, Greenway Health, LLC, 2013

Clinical Trials

Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus Start of enrollment: 2010 Jun 18
Completed
Phase 3
Study of Debio 1450 for Bacterial Skin Infections Start of enrollment: 2015 May 01
Completed
Phase 2
SER-109 Versus Placebo to Prevent Recurrent Clostridium Difficile Infection (RCDI) Start of enrollment: 2015 May 01
Completed
Phase 2
Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM Start of enrollment: 2015 Sep 01
Completed
Phase 2
Evaluate the Safety and Efficacy of Saroglitazar Mg in Patients With Fasting Triglyceride ≥500 mg/dL and ≤1500 mg/dL Start of enrollment: 2017 Apr 06
Suspended
Phase 2
A Study to Test Whether Different Doses of BI 456906 Are Effective in Treating Adults With Type 2 Diabetes. Start of enrollment: 2020 Apr 30
Completed
Phase 2
An Exploratory, Open-Label, Oligo-Center Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Intravenous DNV3837 in Subjects With Clostridium Difficile Infection Start of enrollment: 2019 Aug 02
Recruiting
Phase 2
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

60 citations
Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial.
George R Thompson 3rd, Alex Soriano, Oliver A Cornely, Bart Jan Kullberg, Marin Kollef
Lancet. 2023-01-07
435 citations
Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine.
Ann R. Falsey, Magdalena E. Sobieszczyk, Ian Hirsch, Stephanie Sproule, Merlin L. Robb
The New England Journal of Medicine. 2021-09-29
7 citations
Selective Brain Hypothermia in Acute Ischemic Stroke: Reperfusion Without Reperfusion Injury.
Jae H. Choi, Sven Poli, Michael Chen, Thanh N. Nguyen, Jeffrey L. Saver
Frontiers in Neurology. 2020-11-13